During the past decade, Höpital Hautepierre; Pediatrie1 conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 4 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Höpital Hautepierre; Pediatrie1" are "Crohn Disease" (2 trials), "Fractures in Children" (2 trials), "Ulcerative Colitis" (2 trials), "Anemia" (1 trials) and "Cleft Lip" (1 trials). Many other conditions were trialed in "Höpital Hautepierre; Pediatrie1" in a lesser frequency.

Most popular intervention types in "Höpital Hautepierre; Pediatrie1" are "Drug" (7 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Etrolizumab" (3 trials), "Placebo" (2 trials), "Etrozulimab" (1 trials), "Methoxy Polyethylene Glycol-Epoetin Beta" (1 trials) and "Mircera" (1 trials). Other intervention names were less common.

The vast majority of trials in "Höpital Hautepierre; Pediatrie1" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Höpital Hautepierre; Pediatrie1". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Höpital Hautepierre; Pediatrie1, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Höpital Hautepierre; Pediatrie1, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".